Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Pain Management Market Research Reports

Titlepublishedprice

Global Pain Partnering 2010 to 2017

By Current Partnering
"...... ts since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals listed by compa......"
01-Apr-2017$1495

Visceral Pain - Pipeline Review, H1 2017

By Global Markets Direct
"...... br /> Visceral pain is a type of nociceptive pain that comes from the internal organs. Symptoms include aches, cramps and diffuse pain. Treatment includes analgesics such as narcotics or NSAIDs and pain modifiers such as tricyclic antidepressants or ......"
15-Mar-2017$2000

Post-Operative Pain - Pipeline Review, H1 2017

By Global Markets Direct
"...... to patients. Degree of postoperative pain experienced by individuals varies. Cause of pain includes peripheral nerve damage during surgery, inflammation at the site of the wound and damage to bodily tissues during surgery. Risk factors include site o......"
28-Feb-2017$2000

Hyperalgesia - Pipeline Review, H1 2017

By Global Markets Direct
"...... pioid usage, inflammation, damage to nociceptors, damage to peripheral nerves and psychological disorders. Treatment includes antidepressants and Non-steroidal anti-inflammatory drugs.Report HighlightsGlobal Markets Direct's Ph......"
28-Feb-2017$2000

Moderate Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... to understand the market and pipeline status of the drugs around the Moderate Pain to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Report......"
01-Jan-2017$2000

Musculoskeletal Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... ain Report is to understand the market and pipeline status of the drugs around the Musculoskeletal Pain to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The ......"
01-Jan-2017$2000

Post-Operative Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... n Report is to understand the market and pipeline status of the drugs around the Post-Operative Pain to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The Del......"
01-Jan-2017$2000

Mild Pain-Pipeline Insights, 2017

By Delve Insight
"...... Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. Del......"
01-Jan-2017$1250

Moderate Pain-Pipeline Insights, 2017

By Delve Insight
"...... Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations deta......"
01-Jan-2017$1250

Acute Pain-API Insights, 2017

By Delve Insight
"...... market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process......"
01-Jan-2017$1250

Avail upto 25% Discount on below Publisher Reports.